Term Name: pralatrexate
Synonyms: (2S)-2-((4-((1RS)-1-((2,4-Diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid, (2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid, 10-Propargyl-10-deazaaminopterin, Folotyn, HSDB 7786, N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid, N-{4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid, pralatrexate, pralatrexato, pralatrexatum
Definition: A pteridine that is the N-4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl derivative of L-glutamic acid. Used for treatment of Peripheral T-Cell Lymphoma, an aggressive form of non-Hodgkins lymphoma.
Ontology: ChEBI [CHEBI:71223]  ( EBI )

Relationships
is a type of: N-acyl-L-glutamic acid pteridines terminal acetylenic compound
has_role: antimetabolite antineoplastic agent EC 1.5.1.3 (dihydrofolate reductase) inhibitor